SE420311B - N-alkenyl-2-hydroximetyl-3,4,5-trihydroxipiperidin - Google Patents
N-alkenyl-2-hydroximetyl-3,4,5-trihydroxipiperidinInfo
- Publication number
- SE420311B SE420311B SE7903336A SE7903336A SE420311B SE 420311 B SE420311 B SE 420311B SE 7903336 A SE7903336 A SE 7903336A SE 7903336 A SE7903336 A SE 7903336A SE 420311 B SE420311 B SE 420311B
- Authority
- SE
- Sweden
- Prior art keywords
- hydroxymethyl
- trihydroxypiperidine
- methanol
- alkenyl
- water
- Prior art date
Links
- 150000001875 compounds Chemical class 0.000 claims description 11
- 201000001421 hyperglycemia Diseases 0.000 claims description 4
- 125000001189 phytyl group Chemical group [H]C([*])([H])/C([H])=C(C([H])([H])[H])/C([H])([H])C([H])([H])C([H])([H])[C@@](C([H])([H])[H])([H])C([H])([H])C([H])([H])C([H])([H])[C@@](C([H])([H])[H])([H])C([H])([H])C([H])([H])C([H])([H])C(C([H])([H])[H])([H])C([H])([H])[H] 0.000 claims description 4
- 239000002253 acid Substances 0.000 claims description 3
- 239000003814 drug Substances 0.000 claims description 3
- 150000003839 salts Chemical class 0.000 claims description 3
- 201000010099 disease Diseases 0.000 claims description 2
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 claims description 2
- 230000000069 prophylactic effect Effects 0.000 claims description 2
- 208000024891 symptom Diseases 0.000 claims description 2
- 229940124597 therapeutic agent Drugs 0.000 claims description 2
- GVNVAWHJIKLAGL-UHFFFAOYSA-N 2-(cyclohexen-1-yl)cyclohexan-1-one Chemical compound O=C1CCCCC1C1=CCCCC1 GVNVAWHJIKLAGL-UHFFFAOYSA-N 0.000 claims 1
- 101150065749 Churc1 gene Proteins 0.000 claims 1
- 102100038239 Protein Churchill Human genes 0.000 claims 1
- OKKJLVBELUTLKV-UHFFFAOYSA-N Methanol Chemical compound OC OKKJLVBELUTLKV-UHFFFAOYSA-N 0.000 description 30
- VLKZOEOYAKHREP-UHFFFAOYSA-N n-Hexane Chemical compound CCCCCC VLKZOEOYAKHREP-UHFFFAOYSA-N 0.000 description 15
- 239000000126 substance Substances 0.000 description 15
- LXBIFEVIBLOUGU-UHFFFAOYSA-N 1-deoxynojirimycin Chemical class OCC1NCC(O)C(O)C1O LXBIFEVIBLOUGU-UHFFFAOYSA-N 0.000 description 11
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 description 9
- CSCPPACGZOOCGX-UHFFFAOYSA-N Acetone Chemical compound CC(C)=O CSCPPACGZOOCGX-UHFFFAOYSA-N 0.000 description 8
- BWHMMNNQKKPAPP-UHFFFAOYSA-L potassium carbonate Chemical compound [K+].[K+].[O-]C([O-])=O BWHMMNNQKKPAPP-UHFFFAOYSA-L 0.000 description 8
- LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 description 7
- UHOVQNZJYSORNB-UHFFFAOYSA-N Benzene Chemical compound C1=CC=CC=C1 UHOVQNZJYSORNB-UHFFFAOYSA-N 0.000 description 6
- IAZDPXIOMUYVGZ-UHFFFAOYSA-N Dimethylsulphoxide Chemical compound CS(C)=O IAZDPXIOMUYVGZ-UHFFFAOYSA-N 0.000 description 6
- ZMXDDKWLCZADIW-UHFFFAOYSA-N N,N-Dimethylformamide Chemical compound CN(C)C=O ZMXDDKWLCZADIW-UHFFFAOYSA-N 0.000 description 6
- QGZKDVFQNNGYKY-UHFFFAOYSA-N ammonia Natural products N QGZKDVFQNNGYKY-UHFFFAOYSA-N 0.000 description 6
- 238000006243 chemical reaction Methods 0.000 description 6
- 239000000203 mixture Substances 0.000 description 6
- VYPSYNLAJGMNEJ-UHFFFAOYSA-N Silicium dioxide Chemical compound O=[Si]=O VYPSYNLAJGMNEJ-UHFFFAOYSA-N 0.000 description 5
- 230000015572 biosynthetic process Effects 0.000 description 5
- 239000000741 silica gel Substances 0.000 description 5
- 229910002027 silica gel Inorganic materials 0.000 description 5
- 238000003786 synthesis reaction Methods 0.000 description 5
- HEDRZPFGACZZDS-UHFFFAOYSA-N Chloroform Chemical compound ClC(Cl)Cl HEDRZPFGACZZDS-UHFFFAOYSA-N 0.000 description 4
- VEXZGXHMUGYJMC-UHFFFAOYSA-N Hydrochloric acid Chemical compound Cl VEXZGXHMUGYJMC-UHFFFAOYSA-N 0.000 description 4
- LRHPLDYGYMQRHN-UHFFFAOYSA-N N-Butanol Chemical compound CCCCO LRHPLDYGYMQRHN-UHFFFAOYSA-N 0.000 description 4
- -1 alkenyl halide Chemical class 0.000 description 4
- 238000000034 method Methods 0.000 description 4
- 229910000027 potassium carbonate Inorganic materials 0.000 description 4
- 238000003756 stirring Methods 0.000 description 4
- WORJEOGGNQDSOE-UHFFFAOYSA-N chloroform;methanol Chemical compound OC.ClC(Cl)Cl WORJEOGGNQDSOE-UHFFFAOYSA-N 0.000 description 3
- 239000003480 eluent Substances 0.000 description 3
- 239000000499 gel Substances 0.000 description 3
- 238000005342 ion exchange Methods 0.000 description 3
- 238000002844 melting Methods 0.000 description 3
- 230000008018 melting Effects 0.000 description 3
- 229920001467 poly(styrenesulfonates) Polymers 0.000 description 3
- JOXIMZWYDAKGHI-UHFFFAOYSA-N toluene-4-sulfonic acid Chemical compound CC1=CC=C(S(O)(=O)=O)C=C1 JOXIMZWYDAKGHI-UHFFFAOYSA-N 0.000 description 3
- FOFMBFMTJFSEEY-YFVJMOTDSA-N (2e,6e)-1-bromo-3,7,11-trimethyldodeca-2,6,10-triene Chemical compound CC(C)=CCC\C(C)=C\CC\C(C)=C\CBr FOFMBFMTJFSEEY-YFVJMOTDSA-N 0.000 description 2
- JVDWKJQBWSKJOJ-UHFFFAOYSA-N 1-bromo-3-methylbuta-1,3-diene Chemical compound CC(=C)C=CBr JVDWKJQBWSKJOJ-UHFFFAOYSA-N 0.000 description 2
- VHUUQVKOLVNVRT-UHFFFAOYSA-N Ammonium hydroxide Chemical compound [NH4+].[OH-] VHUUQVKOLVNVRT-UHFFFAOYSA-N 0.000 description 2
- RTZKZFJDLAIYFH-UHFFFAOYSA-N Diethyl ether Chemical compound CCOCC RTZKZFJDLAIYFH-UHFFFAOYSA-N 0.000 description 2
- 125000003342 alkenyl group Chemical group 0.000 description 2
- 229910021529 ammonia Inorganic materials 0.000 description 2
- 239000008280 blood Substances 0.000 description 2
- 210000004369 blood Anatomy 0.000 description 2
- 239000007795 chemical reaction product Substances 0.000 description 2
- 238000004440 column chromatography Methods 0.000 description 2
- 230000002401 inhibitory effect Effects 0.000 description 2
- 230000005764 inhibitory process Effects 0.000 description 2
- 239000002798 polar solvent Substances 0.000 description 2
- 239000000047 product Substances 0.000 description 2
- 125000006239 protecting group Chemical group 0.000 description 2
- 239000000243 solution Substances 0.000 description 2
- 239000000725 suspension Substances 0.000 description 2
- CRDAMVZIKSXKFV-UHFFFAOYSA-N trans-Farnesol Natural products CC(C)=CCCC(C)=CCCC(C)=CCO CRDAMVZIKSXKFV-UHFFFAOYSA-N 0.000 description 2
- 238000005406 washing Methods 0.000 description 2
- WLAUCMCTKPXDIY-JXMROGBWSA-N (2e)-1-chloro-3,7-dimethylocta-2,6-diene Chemical compound CC(C)=CCC\C(C)=C\CCl WLAUCMCTKPXDIY-JXMROGBWSA-N 0.000 description 1
- CPELXLSAUQHCOX-UHFFFAOYSA-N Hydrogen bromide Chemical compound Br CPELXLSAUQHCOX-UHFFFAOYSA-N 0.000 description 1
- AMAJOZOSDKWXOJ-UHFFFAOYSA-L O[Cr](O)(=O)=O.C1=CC=CC=C1 Chemical compound O[Cr](O)(=O)=O.C1=CC=CC=C1 AMAJOZOSDKWXOJ-UHFFFAOYSA-L 0.000 description 1
- 241000700159 Rattus Species 0.000 description 1
- CZMRCDWAGMRECN-UGDNZRGBSA-N Sucrose Chemical compound O[C@H]1[C@H](O)[C@@H](CO)O[C@@]1(CO)O[C@@H]1[C@H](O)[C@@H](O)[C@H](O)[C@@H](CO)O1 CZMRCDWAGMRECN-UGDNZRGBSA-N 0.000 description 1
- 229930006000 Sucrose Natural products 0.000 description 1
- 229910052783 alkali metal Inorganic materials 0.000 description 1
- 229910000288 alkali metal carbonate Inorganic materials 0.000 description 1
- 150000008041 alkali metal carbonates Chemical class 0.000 description 1
- 150000008044 alkali metal hydroxides Chemical class 0.000 description 1
- 150000001408 amides Chemical class 0.000 description 1
- RTEXIPZMMDUXMR-UHFFFAOYSA-N benzene;ethyl acetate Chemical compound CCOC(C)=O.C1=CC=CC=C1 RTEXIPZMMDUXMR-UHFFFAOYSA-N 0.000 description 1
- MDHYEMXUFSJLGV-UHFFFAOYSA-N beta-phenethyl acetate Natural products CC(=O)OCCC1=CC=CC=C1 MDHYEMXUFSJLGV-UHFFFAOYSA-N 0.000 description 1
- 239000003093 cationic surfactant Substances 0.000 description 1
- 239000003153 chemical reaction reagent Substances 0.000 description 1
- 239000003795 chemical substances by application Substances 0.000 description 1
- 238000001816 cooling Methods 0.000 description 1
- 238000010790 dilution Methods 0.000 description 1
- 239000012895 dilution Substances 0.000 description 1
- 229940079593 drug Drugs 0.000 description 1
- 238000000921 elemental analysis Methods 0.000 description 1
- 238000001704 evaporation Methods 0.000 description 1
- 230000008020 evaporation Effects 0.000 description 1
- 238000000605 extraction Methods 0.000 description 1
- 238000010438 heat treatment Methods 0.000 description 1
- 125000002887 hydroxy group Chemical group [H]O* 0.000 description 1
- 239000002198 insoluble material Substances 0.000 description 1
- 239000012454 non-polar solvent Substances 0.000 description 1
- 239000003444 phase transfer catalyst Substances 0.000 description 1
- 230000001766 physiological effect Effects 0.000 description 1
- 239000000843 powder Substances 0.000 description 1
- 238000002360 preparation method Methods 0.000 description 1
- 238000000746 purification Methods 0.000 description 1
- 239000011541 reaction mixture Substances 0.000 description 1
- 239000005720 sucrose Substances 0.000 description 1
- 238000010189 synthetic method Methods 0.000 description 1
- 239000011345 viscous material Substances 0.000 description 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D211/00—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings
- C07D211/04—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom
- C07D211/06—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members
- C07D211/36—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
- C07D211/40—Oxygen atoms
- C07D211/44—Oxygen atoms attached in position 4
- C07D211/46—Oxygen atoms attached in position 4 having a hydrogen atom as the second substituent in position 4
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- Diabetes (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Hematology (AREA)
- Obesity (AREA)
- Emergency Medicine (AREA)
- General Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Endocrinology (AREA)
- Pharmacology & Pharmacy (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Hydrogenated Pyridines (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Steroid Compounds (AREA)
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| JP53051023A JPS5943946B2 (ja) | 1978-04-28 | 1978-04-28 | Ｎ−アルケニルモラノリン誘導体 |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| SE7903336L SE7903336L (sv) | 1979-10-29 |
| SE420311B true SE420311B (sv) | 1981-09-28 |
Family
ID=12875196
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| SE7903336A SE420311B (sv) | 1978-04-28 | 1979-04-17 | N-alkenyl-2-hydroximetyl-3,4,5-trihydroxipiperidin |
Country Status (11)
| Country | Link |
|---|---|
| JP (1) | JPS5943946B2 (da) |
| AT (1) | AT371438B (da) |
| BE (1) | BE875799A (da) |
| CH (1) | CH639373A5 (da) |
| DE (1) | DE2909646C3 (da) |
| DK (1) | DK149750C (da) |
| FR (1) | FR2424258A1 (da) |
| GB (1) | GB2019843B (da) |
| IT (1) | IT1116869B (da) |
| NL (1) | NL179053C (da) |
| SE (1) | SE420311B (da) |
Families Citing this family (6)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| DE2925943A1 (de) * | 1979-06-27 | 1981-01-29 | Bayer Ag | 1-alkadien-2,4-yl-2-hydroxymethyl3,4,5-trihydroxypiperidine, verfahren zu ihrer herstellung und ihre verwendung als arzneimittel |
| JPS56108767A (en) * | 1980-01-28 | 1981-08-28 | Nippon Shinyaku Co Ltd | Bismoranoline derivative |
| GB8827701D0 (en) * | 1987-12-09 | 1988-12-29 | Nippon Shinyaku Co Ltd | Thrombolytic &c compositions |
| US5536732A (en) * | 1990-04-27 | 1996-07-16 | Merrell Pharmaceuticals Inc. | N-derivatives of 1-deoxy nojirimycin |
| US5252587A (en) * | 1990-04-27 | 1993-10-12 | Merrell Dow Pharmaceuticals, Inc. | N-derivatives of 1-deoxy nojirimycin |
| JP2016510306A (ja) * | 2012-05-08 | 2016-04-07 | セリックスビオ プライヴェート リミテッド | 高血糖の治療のための組成物及び方法 |
Family Cites Families (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| NO154918C (no) * | 1977-08-27 | 1987-01-14 | Bayer Ag | Analogifremgangsmaate til fremstilling av terapeutisk aktive derivater av 3,4,5-trihydroksypiperidin. |
-
1978
- 1978-04-28 JP JP53051023A patent/JPS5943946B2/ja not_active Expired
-
1979
- 1979-03-07 GB GB7908030A patent/GB2019843B/en not_active Expired
- 1979-03-12 DE DE2909646A patent/DE2909646C3/de not_active Expired
- 1979-04-17 SE SE7903336A patent/SE420311B/sv not_active IP Right Cessation
- 1979-04-18 FR FR7909795A patent/FR2424258A1/fr active Granted
- 1979-04-18 NL NLAANVRAGE7903017,A patent/NL179053C/xx not_active IP Right Cessation
- 1979-04-20 IT IT48802/79A patent/IT1116869B/it active
- 1979-04-23 BE BE0/194793A patent/BE875799A/xx not_active IP Right Cessation
- 1979-04-25 AT AT0310779A patent/AT371438B/de not_active IP Right Cessation
- 1979-04-26 DK DK172479A patent/DK149750C/da not_active IP Right Cessation
- 1979-04-26 CH CH395579A patent/CH639373A5/de not_active IP Right Cessation
Also Published As
| Publication number | Publication date |
|---|---|
| SE7903336L (sv) | 1979-10-29 |
| GB2019843A (en) | 1979-11-07 |
| NL179053C (nl) | 1986-07-01 |
| DK172479A (da) | 1979-10-29 |
| CH639373A5 (de) | 1983-11-15 |
| DE2909646A1 (de) | 1979-10-31 |
| JPS54144380A (en) | 1979-11-10 |
| IT7948802A0 (it) | 1979-04-20 |
| DK149750B (da) | 1986-09-22 |
| NL7903017A (nl) | 1979-10-30 |
| JPS5943946B2 (ja) | 1984-10-25 |
| FR2424258B1 (da) | 1981-12-11 |
| IT1116869B (it) | 1986-02-10 |
| ATA310779A (de) | 1982-11-15 |
| FR2424258A1 (fr) | 1979-11-23 |
| AT371438B (de) | 1983-06-27 |
| BE875799A (fr) | 1979-08-16 |
| DE2909646C3 (de) | 1980-09-11 |
| GB2019843B (en) | 1982-08-04 |
| DK149750C (da) | 1987-12-14 |
| DE2909646B1 (de) | 1980-01-10 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| SE451017B (sv) | Cinnamylmoranolin-derivat | |
| SU1356960A3 (ru) | Способ получени производных пиридазина | |
| PL91729B1 (da) | ||
| JPH01131156A (ja) | ピペリジン誘導体 | |
| SE420311B (sv) | N-alkenyl-2-hydroximetyl-3,4,5-trihydroxipiperidin | |
| JPS6216942B2 (da) | ||
| US4315862A (en) | Process for preparing cannabichromene | |
| EP0255894A2 (de) | Pyrimidinderivate, deren Herstellung und Arzneimittel, die diese Derivate enthalten | |
| JPS6312063B2 (da) | ||
| EP0211157B1 (de) | Isoxazolderivate, Verfahren zu ihrer Herstellung und diese enthaltende pharmazeutischen Präparate | |
| US4161533A (en) | 5-Sulfamoyl-orthanilic acids and process for their preparation | |
| DE3218743C2 (da) | ||
| US3322778A (en) | Novel ether derivatives of benzmorphans | |
| SE434835B (sv) | N-(1-metyl-2-pyrrolidinylmetyl)-2,3-dimetoxi-5-metylsulfamoyl-bensamid, dess framstellning och farmakologisk komposition innehallande denna nya bensamid | |
| FR2478094A1 (fr) | Derives de cinnamylmoranoline a substitution ammonio, a activite d'inhibition de l'augmentation de niveau de sucre dans le sang | |
| JPS6042795B2 (ja) | カルバモイルピペラジン誘導体 | |
| KR820001082B1 (ko) | 모라노린 유도체의 제조방법 | |
| KR820001124B1 (ko) | N-알케닐 몰라노린 유도체의 제법 | |
| JPS6026387B2 (ja) | シンナミルモラノリン誘導体 | |
| Tronchet et al. | Synthesis of pyrazole C-glycosides by 1, 3-dipolar cycloaddition of nitrilimines formed by lead tetraacetate oxidation of p-nitrophenylhydrazones of aldehydo sugars | |
| KR820001122B1 (ko) | N-알케닐 몰라노린 유도체의 제조방법 | |
| SU820663A3 (ru) | Способ получени замещенных 2-винилхромоновили иХ СОлЕй | |
| US3028386A (en) | 4-(dichloroacet-nu-methyl amido) phenyl-2-furoate | |
| US4187311A (en) | 3-Aryloxy-1-carboalkoxyethylpyridinium compounds and compositions | |
| US4066670A (en) | N-dimethylaminopropyl-5-(2-nitrophenyl)-2-furancarboximidamide dihydrochloride monohydrate |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| NUG | Patent has lapsed |
Ref document number: 7903336-1 Effective date: 19941110 Format of ref document f/p: F |